Metraipolis › archive › dc_249fec19f59a
Kefiran as a Novel Biomaterial Ink Component: Preliminary Assessment of 3D Printing Feasibility and Biocompatibility — Europe PMC PMID:42042117
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42042117
- DOI
- 10.3390/gels12040279
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-03T20:21:47.818Z
- SHA-256 of the archived text
68a04d1756631e994637f2236e91ad47640bab8e0612146da81c790ac3e6db5f- Stable URL of this page
https://metraipolis.com/documento/dc_249fec19f59a
How to cite
Kefiran as a Novel Biomaterial Ink Component: Preliminary Assessment of 3D Printing Feasibility and Biocompatibility — Europe PMC PMID:42042117 — Europe PMC (en), https://europepmc.org/article/MED/42042117 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_249fec19f59a (Metraipolis archive dc_249fec19f59a, sha256 68a04d1756631e994637f2236e91ad47640bab8e0612146da81c790ac3e6db5f)
BibTeX
@misc{dc249fec19f59a,
title = {Kefiran as a Novel Biomaterial Ink Component: Preliminary Assessment of 3D Printing Feasibility and Biocompatibility — Europe PMC PMID:42042117},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42042117},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_249fec19f59a; sha256 68a04d1756631e994637f2236e91ad47640bab8e0612146da81c790ac3e6db5f},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42042117. Agents can read the archived copy with the MCP tool read_document.